Extend Biosciences
Monday, June 03, 2024
Company Presentation
![Metabolic Diseases](https://cdn.asp.events/CLIENT_BIO_7BB99CBA_BAD1_B8C8_CF9F25DA29A80CC6/sites/BIOIC-2024/media/icons/seminars/blank.png)
Company Presentation Theater 2
Extend Biosciences Inc. is a clinical stage biotechnology company developing a novel D-VITylation® drug delivery platform technology that improves the pharmacokinetic properties of peptides and proteins. Peptides have been particularly challenging to bring to market because they are removed from circulation prior to administering therapeutic value.
![Extend Biosciences](https://www.abstractscorecard.com/uploads/Tasks/upload/21754/XDQDGWMO-1811625-1-JPG.jpg)
Company Website:
http://www.extendbio.com
Lead Product in Development:
EXT608
Company HQ City
Newton
Company HQ State
MA
Company HQ Country
United States
CEO/Top Company Official
Tarik Soliman
Development Phase of Primary Product
Phase II
Primary Speaker